In Conversation

"Medelys is always up-to-date, and in the treatment of joint pain and skin regeneration, there is still room for improvement in the formulation of our products."

"Essentially, what we are expecting is a facilitated market access route for OTC products and generics"

"We decided to match my knowledge with my wife’s firsthand experience to create our own approach to laboratory solutions in Serbia, using the network and expertise…

"At JSS, we are not just a pure academic CRO, although we nurture academic development, but we also serve industry at the same time."

"We decided to enter the pharma world given the strengthening of regulation on the temperature control of products, notably vaccines."

"Searchlight is a unique company, in that what drives our thinking from a business development and commercial perspective, is that we do not think about healthcare…

"In the healthcare market, Poland is safe to invest, no matter the regulations."

"Canada could find advantage by positioning itself as a country of excellence for smaller studies or more complex studies requiring innovative designs, the type ethica CRO…

"Currently CMED's main objective is to move forward with the regulatory apparatus for the new challenges and promote transparency."

"Switzerland is home to a significantly high amount of regional headquarters of global pharma and biotech companies. Chances are that if they are our clients in…

"In Austria, we will generate higher revenues than in 2016. It has hence been a good year for us"

"Our Canadian affiliate has also proven a pronounced capacity in pioneering when it comes to internal initiatives and positioned itself as an exporter of best practices."

We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here